Latest filing published 29 Apr 2026 for Medtronic plc.
Of the 88 filings under Scott C. Donnelly's name, 65 come from Textron Inc, where Donnelly appears as Chairman, President & CEO. The other 23 come from Medtronic plc, where Donnelly is a Director. They run from March 3, 2016 to April 29, 2026.
The 21 sales, all at Textron, add up to EUR 129,863,834, with a median of EUR 5,610,379. The three largest date from February 15, 2024 (EUR 19,209,133), February 14, 2024 (EUR 15,692,400) and February 21, 2023 (EUR 13,638,654). No purchase is filed. The rest is made of 48 share grants and 19 option exercises.
Annual volume peaks at 14 filings in 2018, followed by 12 in 2019 and 10 in 2022, while 2025 has 4. Eight filings fall in the last twelve months, 3 of them sales.
Filings appear a median of 2 days after the trade. At Textron, 16 of Donnelly's open-market trades fall within 30 days of a trade by Frank T. Connor, 13 within 30 days of one by Mark S. Bamford and 10 within 30 days of one by E. Robert Lupone, all in the same direction.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 88 declarations